Oxford Industries Stock Plummets on Drastic Guidance Cut, Lilly Pulitzer Weakness

Shares of Oxford Industries (OXM) plunged in pre-market trading after the apparel company drastically cut its financial outlook for the upcoming quarter and the full fiscal year. The selloff, which saw the stock drop 14.3% to $31.40, came despite second-quarter results that narrowly surpassed analyst expectations.

Dismal Outlook Overshadows Earnings Beat

While Oxford Industries reported Q2 adjusted earnings per share of $1.34, slightly ahead of the $1.30 consensus estimate, investors focused on the company's forward guidance. The revised forecast, issued alongside the earnings report, fell significantly short of market projections.

For the third quarter, the company now expects:

• Revenue between $280 million and $300 million, roughly 7.5% below analyst forecasts.
• An adjusted loss per share ranging from $1.40 to $1.20, far wider than the consensus estimate for a loss of just $0.59.

For the full fiscal year, Oxford slashed its adjusted EPS outlook to a range of $1.60 to $2.00. This marks a sharp reduction from the prior Wall Street consensus of $2.47 per share.

Ad

Lilly Pulitzer Woes and Consumer Headwinds

CEO Tom Chubb attributed the weakened forecast to persistent challenges at the company's Lilly Pulitzer brand, which he said faced issues with its product and marketing. These brand-specific problems are being compounded by broader economic pressures, including "softer consumer sentiment and elevated travel costs weighing on discretionary spending," according to the company.

In response, Oxford Industries plans to increase promotional activity at Lilly Pulitzer. The move is intended to stimulate demand and prevent an accumulation of unsold inventory. The sharp downward revision in guidance suggests these headwinds are proving more severe than previously anticipated.

Market Reaction

The steep decline in Oxford's stock appears to be a company-specific event, as the broader market was relatively flat. The selloff pushed the share price toward its 52-week low of $30.57, erasing recent gains and reflecting a significant blow to investor confidence following the guidance cut.